The need for new control strategies for particulate matter in parenterals

Johannes Poms, Stephan Sacher, Matthias Nixdorf, Michael Dekner, Sabine Wallner-Mang, Ines Janssen, Johannes G. Khinast, Robert Schennach

Publikation: Beitrag in einer FachzeitschriftArtikelForschungBegutachtung

Abstract

An undesirable characteristic in lyophilized parenteral products is the potential presence of particulate matter in the final product, which may affect patient safety. In this study, quality risk management tools described in the International Conference on Harmonization Guideline Q9 were used to estimate the risks for a pharmaceutical manufacturing line, based on three critical quality attributes: (1) visible particulate matter; (2) lyo-cake collapse traces; and (3) lyo-cake melt-back traces. Together with a Process Failure Mode Effect Analysis (PFMEA), an input-output analysis of the individual unit operations identified seven major material classes of extrinsic particulate matter. In addition to the process assessment, an experimental investigation of the location of impurities in lyophilized products was performed. To that end, intentionally contaminated vials were examined to locate the particulate matter and its possible migration. The results emphasize the importance of a full transmission mode release testing since the particles may enter the interior of the lyo-cake. A theoretical explanation of the observed impurity locations is provided.

Originalspracheenglisch
Seiten (von - bis)739-750
Seitenumfang12
FachzeitschriftPharmaceutical development and technology
Jahrgang24
Ausgabenummer6
DOIs
PublikationsstatusVeröffentlicht - 3 Jul 2019

Fingerprint

Particulate Matter
Process Assessment (Health Care)
Risk Management
Patient Safety
Guidelines
Pharmaceutical Preparations

Schlagwörter

    ASJC Scopus subject areas

    • !!Pharmaceutical Science

    Dies zitieren

    The need for new control strategies for particulate matter in parenterals. / Poms, Johannes; Sacher, Stephan; Nixdorf, Matthias; Dekner, Michael; Wallner-Mang, Sabine; Janssen, Ines; Khinast, Johannes G.; Schennach, Robert.

    in: Pharmaceutical development and technology, Jahrgang 24, Nr. 6, 03.07.2019, S. 739-750.

    Publikation: Beitrag in einer FachzeitschriftArtikelForschungBegutachtung

    Poms, Johannes ; Sacher, Stephan ; Nixdorf, Matthias ; Dekner, Michael ; Wallner-Mang, Sabine ; Janssen, Ines ; Khinast, Johannes G. ; Schennach, Robert. / The need for new control strategies for particulate matter in parenterals. in: Pharmaceutical development and technology. 2019 ; Jahrgang 24, Nr. 6. S. 739-750.
    @article{d3e25cefdb2d4dab91b0ec0ecfc69915,
    title = "The need for new control strategies for particulate matter in parenterals",
    abstract = "An undesirable characteristic in lyophilized parenteral products is the potential presence of particulate matter in the final product, which may affect patient safety. In this study, quality risk management tools described in the International Conference on Harmonization Guideline Q9 were used to estimate the risks for a pharmaceutical manufacturing line, based on three critical quality attributes: (1) visible particulate matter; (2) lyo-cake collapse traces; and (3) lyo-cake melt-back traces. Together with a Process Failure Mode Effect Analysis (PFMEA), an input-output analysis of the individual unit operations identified seven major material classes of extrinsic particulate matter. In addition to the process assessment, an experimental investigation of the location of impurities in lyophilized products was performed. To that end, intentionally contaminated vials were examined to locate the particulate matter and its possible migration. The results emphasize the importance of a full transmission mode release testing since the particles may enter the interior of the lyo-cake. A theoretical explanation of the observed impurity locations is provided.",
    keywords = "lyophilization, particulate matter, quality by design, quality control strategy, Quality risk management, visual inspection",
    author = "Johannes Poms and Stephan Sacher and Matthias Nixdorf and Michael Dekner and Sabine Wallner-Mang and Ines Janssen and Khinast, {Johannes G.} and Robert Schennach",
    year = "2019",
    month = "7",
    day = "3",
    doi = "10.1080/10837450.2019.1585449",
    language = "English",
    volume = "24",
    pages = "739--750",
    journal = "Pharmaceutical development and technology",
    issn = "1083-7450",
    publisher = "Informa Healthcare",
    number = "6",

    }

    TY - JOUR

    T1 - The need for new control strategies for particulate matter in parenterals

    AU - Poms, Johannes

    AU - Sacher, Stephan

    AU - Nixdorf, Matthias

    AU - Dekner, Michael

    AU - Wallner-Mang, Sabine

    AU - Janssen, Ines

    AU - Khinast, Johannes G.

    AU - Schennach, Robert

    PY - 2019/7/3

    Y1 - 2019/7/3

    N2 - An undesirable characteristic in lyophilized parenteral products is the potential presence of particulate matter in the final product, which may affect patient safety. In this study, quality risk management tools described in the International Conference on Harmonization Guideline Q9 were used to estimate the risks for a pharmaceutical manufacturing line, based on three critical quality attributes: (1) visible particulate matter; (2) lyo-cake collapse traces; and (3) lyo-cake melt-back traces. Together with a Process Failure Mode Effect Analysis (PFMEA), an input-output analysis of the individual unit operations identified seven major material classes of extrinsic particulate matter. In addition to the process assessment, an experimental investigation of the location of impurities in lyophilized products was performed. To that end, intentionally contaminated vials were examined to locate the particulate matter and its possible migration. The results emphasize the importance of a full transmission mode release testing since the particles may enter the interior of the lyo-cake. A theoretical explanation of the observed impurity locations is provided.

    AB - An undesirable characteristic in lyophilized parenteral products is the potential presence of particulate matter in the final product, which may affect patient safety. In this study, quality risk management tools described in the International Conference on Harmonization Guideline Q9 were used to estimate the risks for a pharmaceutical manufacturing line, based on three critical quality attributes: (1) visible particulate matter; (2) lyo-cake collapse traces; and (3) lyo-cake melt-back traces. Together with a Process Failure Mode Effect Analysis (PFMEA), an input-output analysis of the individual unit operations identified seven major material classes of extrinsic particulate matter. In addition to the process assessment, an experimental investigation of the location of impurities in lyophilized products was performed. To that end, intentionally contaminated vials were examined to locate the particulate matter and its possible migration. The results emphasize the importance of a full transmission mode release testing since the particles may enter the interior of the lyo-cake. A theoretical explanation of the observed impurity locations is provided.

    KW - lyophilization

    KW - particulate matter

    KW - quality by design

    KW - quality control strategy

    KW - Quality risk management

    KW - visual inspection

    UR - http://www.scopus.com/inward/record.url?scp=85063912276&partnerID=8YFLogxK

    U2 - 10.1080/10837450.2019.1585449

    DO - 10.1080/10837450.2019.1585449

    M3 - Article

    VL - 24

    SP - 739

    EP - 750

    JO - Pharmaceutical development and technology

    JF - Pharmaceutical development and technology

    SN - 1083-7450

    IS - 6

    ER -